| Literature DB >> 30884918 |
Bahare Salehi1, Pia Lopez-Jornet2, Eduardo Pons-Fuster López3, Daniela Calina4, Mehdi Sharifi-Rad5, Karina Ramírez-Alarcón6, Katherine Forman7, Marcos Fernández8, Miquel Martorell9, William N Setzer10, Natália Martins11,12, Célia F Rodrigues13, Javad Sharifi-Rad14.
Abstract
Oral mucosal lesions have many etiologies, including viral or bacterial infections, local trauma or irritation, systemic disorders, and even excessive alcohol and tobacco consumption. Folk knowledge on medicinal plants and phytochemicals in the treatment of oral mucosal lesions has gained special attention among the scientific community. Thus, this review aims to provide a brief overview on the traditional knowledge of plants in the treatment of oral mucosal lesions. This review was carried out consulting reports between 2008 and 2018 of PubMed (Medline), Web of Science, Embase, Scopus, Cochrane Database, Science Direct, and Google Scholar. The chosen keywords were plant, phytochemical, oral mucosa, leukoplakia, oral lichen planus and oral health. A special emphasis was given to certain plants (e.g., chamomile, Aloe vera, green tea, and coffea) and plant-derived bioactives (e.g., curcumin, lycopene) with anti-oral mucosal lesion activity. Finally, preclinical (in vitro and in vivo) and clinical studies examining both the safety and efficacy of medicinal plants and their derived phytochemicals were also carefully addressed.Entities:
Keywords: Aloe vera; Matricaria chamomilla; curcumin; lycopene; medicinal plants; oral mucosal lesions; phytochemicals; plant extracts
Mesh:
Substances:
Year: 2019 PMID: 30884918 PMCID: PMC6468600 DOI: 10.3390/biom9030106
Source DB: PubMed Journal: Biomolecules ISSN: 2218-273X
Figure 1Plants and plant-derived bioactives in oral mucosal lesions.
Figure 2Molecular targets of curcumin. AhR, aryl hydrocarbon receptor; ATF, activating transcription factor; AP, activator protein; CBP, P300/CREB-binding protein; CHOP, C/EBP homologous protein; COP, constitutive photomorphogenic; COX, cyclooxygenase; CREB, cAMP response element binding; CSN, COP9 signalosome; CXCL, chemokine ligand; CXCR chemokine receptor; cFLIP, cellular FLICE-like inhibitory protein; CRP, C-reactive protein; DR, death receptor; EGFR, epidermal growth factor receptor; Egr, Early growth response; EpRE, electrophile response element; FAK, focal adhesion kinase; GST, glutathione S-transferase; HIF, hypoxia inducible factor; HSP, heat-shock protein; IAP, inhibitor of apoptosis protein; IL, interleukin; LOX, lipoxygenase; MMP, matrix metallopeptidase; MRP, multidrug resistance protein; NQO, naphthoquinone oxidoreductase; NADP(H), nicotinamide adenine dinucleotide phosphate (reduced form); Nrf2, NFE2-related factor; NF-κB, nuclear factor-kappa B; MRP, multi-drug resistance protein; PPAR-γ, peroxisome-proliferator-activated receptor-gamma; PKA, protein kinase A; PKC, protein kinase C; PSA, prostatic specific antigen; STAT, signal transducers and activators of transcription protein; TNF, tumor necrosis factor; uPA, urokinase plaminogen activator; VEGF, vascular endothelial growth factor; XIAP, X-linked IAP, XO, xanthine oxidase.
Properties and signaling pathways of curcumin.
|
|
COX-1, COX-2, LOX, TNF-α, IFN-γ, iNOS and NF-κB inhibition [ Down-regulates MCP-1 expression [ Inhibits inflammatory cytokines production: IL-1β, IL-2, IL-5, IL-6, IL-8, IL-12, IL-18, MIP-1α [ Down-regulates mitogen-activated and Janus kinases [ |
|
|
Cyclin D1 and CDK4 inhibition and p53, pRb, p21 and p27 up-regulation [ Induced retinoblastoma protein [ |
|
|
Induced up-regulation of Fas, FasL and DR5 expression [ Enhances procaspases 3, 8 and 9 and poly(ADP-ribose) polymerase cleavage [ |
COX, cyclooxygenase; DR, death receptor; IFN, interferon; IL, interleukin; iNOS, inducible nitric oxide synthase; CDK, cyclin-dependent kinase; LOX, lipoxygenase; MCP, monocyte chemoattractant protein; MIP, macrophage inflammatory protein; NF-κB, nuclear factor kappa B; STAT, signal transducer and activator of transcription; TNF, tumor necrosis factor, pRB retinoblastoma protein; STAT, signal transducer and activator of transcription; FasL, Fas ligand.
Actions of Aloe vera components.
| Action | Treatment | Reference |
|---|---|---|
| Ointment 10 mg/g/day for eight days, topically applied in an affected area | [ | |
| A cream containing 0.5% | [ | |
| 50 mg/kg/day for six weeks orally | [ | |
| [ |
Human evidence of plants and phytochemicals against oral mucosal lesions.
| Phytochemicals/Plants | Diseases | Observations | Ref. |
|---|---|---|---|
| Curcumin | Leukoplakia, lichen planus, and oral submucous fibrosis | Anti-tumor activity increasing vitamins C and E levels and preventing lipid peroxidation and DNA damage | Rai et al. [ |
| Oral lichen planus | Reduction of symptoms and signs | Chainani-Wu et al. [ | |
| Reduction in signs (erythema and ulceration level) | Chainani-Wu et al. [ | ||
| Signs disappeared with no adverse effects | Sumanth et al. [ | ||
| Curcumin, | Chemoradiotherapy-induced oral mucosal lesion | Prevention and treatment without associated inflammatory process | dos Santos et al. [ |
| Lycopene | Moderate periodontitis, moderate gingivitis | Effect as an adjunct to oral prophylaxis | Belludi et al. [ |
| Gingivitis | Reduced gingivitis, bleeding index and non-invasive measures of plaque | Chandra et al. [ | |
| Lycopene, β-carotene | Leukoplakia | Association between leukoplakia and low serum lycopene and β-carotene levels | Nagao et al. [ |
| Atrophic/erosive oral lichen planus | Association between oral lichen planus and low serum lycopene levels | Nagao et al. [ | |
| Green tea | Periodontal disease | Bactericidal effect | Hirasawa et al. [ |
| Chronic periodontitis | Green tea dentifrice improved probing depth, gingival index, and clinical attachment level | Hrishi et al. [ | |
| Coffee | Cancer of the oral cavity and pharynx | Caffeinated coffee intake was inversely related to a cancer risk of the oral cavity and pharynx | Galeone et al. [ |
| Coffee, honey | Oral mucositis | Oral mucositis can be successfully treated by a combination of honey and coffee | Raeessi et al. [ |
| Chamomile | Methotrexate-induced oral mucositis | Successfully reduced with mouthwash treatment | Mazokopakis et al. [ |
| Oral mucositis | Lower mouth pain score and fewer ulcerations | dos Reis et al. [ | |
|
| Radiation-induced mucositis | No beneficial effect reported as an adjunct to head-and-neck radiotherapy | Su et al. [ |
| Oral candidiasis | Reduced oral candidiasis in patients with head and neck radiotherapy | Ahmadi et al. [ | |
| Oral lichen planus | Reduced pain and burning sensation score, size and clinical characteristics of the lesions | Mansourian et al. [ | |
| Induced clinical and symptom improvement | Choonhakarn et al. [ |